Abstract: Hypertension is one of the most common chronic diseases as well as the leading risk factor for cardiovascular disease (CVD). Efficient screening and accurate blood pressure (BP) monitoring are the basic methods of detection and management. However, with developments in electronic technology, BP measurement and monitoring are no longer limited to the physician's office. Epidemiological and clinical studies have documented strong evidence for the efficacy of out-of-office BP monitoring in multiple fields for managing hypertension and CVD. This review discusses applications for out-of-office BP monitoring, including home blood pressure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM), based on recent epidemiological data and clinical studies regarding the following factors: the detection of abnormal BP phenotypes, namely, white coat hypertension and masked hypertension; stronger ability to determine the prognosis for target organ damage and mortality; better BP control; screening for hypotension; and unique approaches to identifying circadian BP patterns and BP variability.
Introduction
Hypertension has long been the most common disease worldwide, with an estimated global pre valence of 1.13 billion people in 2015. 1 In China, according to the latest data from a nationwide survey on hypertension from 2012 to 2015, the adult ageweighted prevalence of hypertension was 23.2%. 2 The 2017 American College of Cardiology/ American Heart Association (ACC/AHA) guide lines for the prevention, detection, evaluation, and management of high blood pressure (BP) in adults revised the cutoff for diagnosing hypertension to ⩾130/80 mm Hg; this means that the prevalence of hypertension will increase to 46% in the USA, 3 and to 46.4% in China, which is twice as high as that based on current Chinese guidelines. 4 Studies show that control of high BP can result in significant risk reductions in cardiovascular morbidity and mortal ity. 5 Office BP measurement (OBPM) has been the standard for diagnosing and managing hyper tension; however, results may be confounded by several factors and are limited by time and location. To improve the rates of detection and control of high BP in the general population, guidelines from different countries and organizations have pro posed several recommendations. These academic statements concur in their recommendations for using outofoffice BP monitoring in patients with hypertension or in highrisk populations. 3, 4, [6] [7] [8] For example, the 2017 ACC/AHA guidelines included an IA (Class of Recommendation and Level of Evidence) recommendation for outofoffice BP measurement to confirm the diagnosis of hyperten sion and to titrate BPlowering medications. 3 The 2018 European Society of Cardiology/European Society of Hypertension guidelines for the manage ment of arterial hypertension also recommended that outofoffice BP measurements should be used to confirm a diagnosis of hypertension, 6 and the 2018 Chinese guidelines for the prevention and treatment of hypertension recommended that, if available, outofoffice BP monitoring should be implemented to diagnose white coat hypertension (WCH) and masked hypertension (MH), or to evaluate the effects of antihypertensive treatment. 4 In addition to its use for diagnosing and manag ing hypertension, outofoffice BP may be practi cal in screening for hypotension, identifying circadian BP patterns and BP variability, and risk stratification for BPrelated target organ damage and mortality. This review aims to summarize the current evidence for the applications of outof office BP monitoring, including home blood pres sure monitoring (HBPM) and ambulatory blood pressure monitoring (ABPM), with regard to cur rent studies on cardiovascular disease (CVD).
General characteristics of OBPM, HBPM, and ABPM
OBPM is measured by a nurse or doctor with a conventional calibrated mercury sphygmomanom eter or an electronic device in the clinic. HBPM, also called selfBP monitoring, is performed by the patient or a family member in a familiar environ ment, providing athome longterm BP values. ABPM offers abundant information on 24h pro files including nocturnal BP and shortterm BP variability. The general characteristics of OBPM, HBPM, and ABPM are listed in Table 1 .
Applications for out-of-office BP monitoring
Detecting WCH and MH Combining OBPM and outofoffice BP read ings, BP phenotypes can be divided into normo tension, WCH, MH, and sustained hypertension. WCH is defined as an elevated inoffice BP and normal outofoffice BP, while MH defines patients with normal inoffice BP but with ele vated outofoffice BP measurements (Figure 1 ).
Studies report that overall prevalence of WCH in the general population is 9-23%, 9-13 and that WCH accounts for 30-40% of patients with ele vated OBPM. 6 WCH has long been considered a benign phenomenon because numerous epide miological studies found no association between WCH and target organ damage. 14, 15 Although some observational studies and metaanalyses showed that WCH was associated with subclini cal target organ damage, the crosssectional design of these studies failed to prove causal ity. 16, 17 Recently, our largescale metaanalysis found that, after multivariate adjustment, WCH was associated with an increased risk of CVD and allcause mortality in individuals without antihypertensive treatment at baseline compared with normotensive counterparts. It is interesting that the risks of CVD and mortality are similar in 19 Similarly, the Ohasama study enrolled 1464 participants, and, with a mean followup of 17.1 years, con cluded that partial WCH (either home or ambu latory normotension with office hypertension) was associated with a longterm risk of stroke. 20 Most recently, an updated metaanalysis that included the Spanish ABPM cohort study also showed that untreated WCH was associated with a significantly increased risk of cardiovascular mortality (HR: 2.09; 95% CI: 1.23-4.48), all cause mortality (HR: 1.33; 95% CI: 1.07-1.67), and CVD (HR: 1.36; 95% CI: 1.03-2.00). 21 MH is defined as elevated outofoffice BP and normal office BP, and has been generally consid ered harmful and to require appropriate treat ment. The prevalence of MH ranges from 6.7% to 20% in different reports. 13, 22, 23 In the Spanish cohort study, after adjusting for multiple risk fac tors, MH defined by ABPM was strongly associ ated with allcause mortality (HR: 2.83; 95% CI: 2.12-3.79) and cardiovascular mortality (HR: 2.85; 95% CI: 1.66-4.90). 19 Another cohort study including 4261 Japanese patients also con cluded that MH based on HBPM was associated with an increased risk of stroke (HR: 2.66; 95% CI: 1.15-6.13). 24 It should be noted that in individuals with prehy pertension defined according to office BP (120-139/80-89 mm Hg), a large proportion would be classified as MH if outofoffice BP monitoring was performed. The International Database on Ambulatory BP in relation to Cardiovascular Outcomes (IDACO) study revealed that, in peo ple with prehypertension, 29.3% would be diag nosed as having MH if ABPM was performed. The Masked Hypertension Study also showed that 34.1% of participants defined as prehyperten sive were confirmed to be MH under ABPM. 25 In addition, the International Database of HOme BP in relation to Cardiovascular Outcome (IDHOCO) study revealed similar findings by HBPM, stating that MH accounted for 18.4% and 30.4% of patients with lowrange (120-129/80-84 mm Hg) and highrange (130-139/85-89 mm Hg) prehy pertension, respectively. Without outofoffice measurements, a large number of patients with MH could be misdiagnosed, which might result in inappropriate treatment. Our series studies showed that prehypertension is associated with an increased risk of allcause mortality, CVD, and endstage renal disease. [26] [27] [28] [29] [30] [31] [32] However, whether this target organ damage is caused by undetected MH or prehypertension is unclear and requires further studies. Based on data from the studies cited previously, outofoffice BP measurement, either HBPM or ABPM, is highly recommended for the detection of WCH or MH in suspected individuals.
Prognostic predictive power of out-of-office BP for target organ damage and mortality
Given the limitations of OBPM, the prognostic predictive power for target organ damage of in office BP may be lower than that of outofoffice BP. Because of rapid developments in electronic technology, numerous studies comparing the prognostic predictive power of outofoffice BP and office BP have been performed. The FinnHome study showed that HBPM is strongly correlated with cardiovascular risk, 33 and is a stronger predictor of left ventricular hypertrophy and atherosclerosis than office BP. [34] [35] [36] The Spanish cohort study demonstrated that 24h sys tolic BP was a better predictor of allcause mor tality (HR: 1.58 per 1standard deviation increase in ABPM; 95% CI: 1.56-1.60, after adjusting for OBPM) than office systolic BP (HR: 1.02; 95% CI: 1.00-1.04, after adjusting for 24h ambula tory BP). 19 Other studies drew a similar conclu sion, namely that HBPM or ABPM can better predict cardiovascular events or other target organ damage. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] Therefore, people who are at high risk, or have elevated BP, should consider outofoffice measurements, which are stronger predictors.
However, it should be noted that currently there are limited data to support the proposal of whether, in the general population, the use of outofoffice BP instead of office BP in CVD risk scoring sys tems can provide further incremental value for CVD prediction. Data from a Swedish cohort study showed that, although ambulatory systolic BP was an independent risk factor for CVD, addi tion to the Framingham Risk Score led to only small increases to the overall model fit, discrimina tion (a 1% increase in the area under the receiver operating characteristic curve), calibration, and reclassification. 47 Recently, another study also showed that using BP measurements obtained through ABPM or HBPM instead of OBPM may have little effect on CVD risk estimates obtained from the Framingham, QRISK2 (risk of develop ing a heart attack or stroke over the next 10 years), or SCORE (Systematic COronary Risk Evaluation) risk equations. 48 Therefore, current cardiovascular risk assessment systems, including ChinaPAR (Prediction for Atherosclerotic CVD [ASCVD] Risk in China), 49 European SCORE, 50 ASCVD PCE (Pooled Cohorts Equations) of the USA, 51 the Q risk score (QRISK) model of Great Britain, 52 and the Framingham Risk Score, 53 include only clinic BP in the model. However, all of these car diovascular risk assessment systems were devel oped in the general population. In patients with abnormal BP phenotypes, such as WCH or MH, current CVD risk assessment systems may over or underestimate the risk. Further studies are needed to explore whether incorporation of outofoffice BP has incremental value for CVD prediction in people with abnormal BP phenotypes.
Better BP control
The Telemonitoring or SelfMonitoring of BP in Hypertension (TASMINH4) trial is a parallel ran domized controlled trial that was performed in the United Kingdom that aimed to evaluate the effi cacy of selfBP monitoring, telemonitoring, and usual care in BP control. In this trial, participants were assigned randomly (1:1:1) to a selfmonitor ing group, a telemonitoring group, or a usual care group. After 12 months, both selfmonitoring and telemonitoring groups had a lower BP level than the usual care group (137.0 ± 16.7 and 136.0 ± 16.1, versus 140.4 ± 16.5 mm Hg).
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Good adherence to therapy is a prerequisite to achieving better BP control. A more recent rand omized controlled trial showed that shortterm HBPM can significantly improve medication adherence and result in greater reduction in office BP. 55 Similarly, a metaanalysis by Duan and col leagues including 46 randomized controlled trials confirmed that HBPM can improve BP control. 56 Other controlled studies and metaanalyses draw similar conclusions, namely, that outofoffice BP monitoring could result in better BP control com pared with OBPM alone. [57] [58] [59] [60] [61] [62] Although it is gener ally accepted that HBPM is useful for better BP control in patients with hypertension, a systematic review showed that HBPM alone is not associated with better BP control, but, with cointerventions, leads to significant BP reduction. 63 To date, it remains uncertain whether HBPM can improve BP control over the longer term. Furthermore, few data on the association of ABPM and BP con trol have been reported. Largescale studies with longer follow up are required to address these issues.
Good BP control plays a pivotal role in reducing the prevalence of CVD. A metaanalysis showed that every 5mm Hg decrease in systolic BP was associated with a 13% lower risk of cardiovascular events, and a 2mm Hg decrease in diastolic BP was associated with a 12% lower risk of cardio vascular events. 64 However, evaluation of the association between BP reduction and CVD was based on office BP values; studies on BP treat ment goals based on HBPM or ABPM are lim ited. Current academic guidelines recommending initiating treatment and determining BP goals for managing hypertension are still based on OBPM.
3,4,6,7 Several ongoing studies are evaluat ing the use of outofoffice BP monitoring to guide hypertension control. The TELEBPMET (a randomized controlled study based on home BP telemonitoring versus conventional manage ment and assessment of psychological determi nants of adherence) study will include a total of 252 patients and randomize them to usual care or home BP telemonitoring. 65 The primary study endpoint will be the rate among subjects of achieving normal daytime ambulatory BP targets. The GYMNs (Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies) study is a prospective doubleblind randomized trial, which is planned to enroll a total of 252 patients and allocate them into three arms: home BP, unattended automated BP, and central BPguided treatment. 66 The pri mary outcome is the change in 24h mean ambu latory systolic BP at 3 months, and the decrease in left ventricular mass will be evaluated at 12 months. However, both the TELEBPMET and GYMNs studies are not designed to evaluate the risk of CVD according to different BP man agement strategies. The MASTER (MASked unconTrolled hypERtension management based on OBPM or ABPM) study is a 4year prospec tive, randomized, openlabel, blindedendpoint investigation, which included 1240 patients with masked uncontrolled hypertension (MUCH) and randomized to a management strategy based on OBPM or on ABPM. 67 The effects of the MUCH management strategy based on OBPM or ABPM on CVD will be assessed at 4 years. The results of these studies will provide more information about the effects of different BPguiding management strategies on the prevention of CVD.
Out-of-office BP monitoring for screening hypotension
Hypotension is usually defined as OBPM < 110/70 mm Hg, daytime ABPM < 105/65 mm Hg, or 24h ABPM < 100/60 mm Hg. 68 Although the 'J curve' phenomenon is still controversial, [69] [70] [71] lower BP readings are undoubtedly not an improve ment. 68, 71 The Systolic Blood Pressure Intervention Trial showed that patients with hypertension and high CVD risk assigned to an intensive BP treat ment goal (systolic BP < 120 mm Hg) experienced lower CVD risk but also increased risk of severe hypotension and syncope. 72 In a study including 70,997 patients with hypertension receiving antihy pertensive treatment, one in eight patients was at risk of hypotension, and ABPM could better screen for hypotension than OBPM. 68 Orthostatic hypotension, a usually asymptomatic condition whereby BP drops when rising to a standing position, has been confirmed to be asso ciated with cardiovascular events and demen tia. [73] [74] [75] [76] [77] Although it is not difficult to diagnose, orthostatic hypotension is rarely screened using OBPM unless obvious symptoms develop. A study by Cremer and colleagues showed that HBPM is better than OBPM in screening for orthostatic hypotension. 78 Another study showed that ABPM can predict autonomic dysfunction in orthostatic hypotension, 79 and may be useful when assessing patients for orthostatic hypoten sion. 80 Postprandial hypotension occurs when systolic BP decreases by more than 20 mm Hg within 2 h after a meal. Some studies have shown that this condition also results in an increased risk of stroke, cerebrovascular damage, syncope, and mortality, [81] [82] [83] and that HBPM is a suitable screening method. 83 Based on these findings, outofoffice BP monitor ing is a good choice for screening for hypotension (including orthostatic and postprandial hypoten sion) in patients with hypertension receiving anti hypertensive treatment (especially older patients) or with normal BP with autonomic dysfunction. If hypotension is documented, modifying a patient's antihypertensive medication or other interventions should be considered. In addition, future studies should focus on individual therapy and optimal thresholds for patients with hypertension in order to avoid undetected hypotension.
Identifying BP variability, circadian BP patterns, and other special BP phenotypes
Variability is an intrinsic property of BP. In patients with regular followup, longterm visit tovisit BP variability is associated more strongly with cardiovascular and allcause mortality than mean BP. 84 HBPM may be more suitable for determining longterm BP variability because it can improve patients' adherence to BP monitor ing. The Didima study showed that, in the gen eral population with a 19year follow up, systolic home BP variability exhibited superior prognostic ability compared with office BP. 85 Although longterm BP variability is not available through ABPM, ABPM can provide shortterm variability data when variability is defined as the average variation of BP throughout the day and the circadian rhythm. Based on 24h BP profiles, normal BP circadian rhythm is defined as dipping BP with a decrease of 10-20% at night compared with daytime. Accordingly, other circadian BP patterns, including extreme dipping (>20% drop), nondipping (<10% drop), and reverse dipping (reversely increased) BP, are also defined by nighttime mean BP compared with daytime BP. 86 Furthermore, ABPM is useful for detecting other special BP phenotypes, such as isolated nocturnal hypertension and morning BP surge. Nondipping BP, [87] [88] [89] reverse dipping BP, 90, 91 nocturnal hypertension, 92, 93 and morning BP surge 88, 89, 94, 95 are associated with an increased risk of target organ damage.
Compared with ABPM, HBPM has been criti cized as being inconvenient for the monitoring of circadian BP patterns and nocturnal hyperten sion. However, recent studies showed that HBPM provided similar values and had close agreement in detecting nondipping BP, as well as target organ damage, compared with ABPM. 96, 97 However, because of limited available data, addi tional studies focusing on circadian BP patterns, BP variability, and special phenotypes detected by HBPM are required to determine the optimal strategies for managing hypertension based on outofoffice measurements, and thus reduce adverse outcomes.
Conclusion
Although outofoffice BP monitoring is benefi cial, it is not as widely used as we propose. Regarding ABPM, the relatively higher expense, interference with daily activities, and inaccurate readings due to incorrect measuring position are the main reasons for its low rate of use. HBPM, moreover, requires formal skills training and is limited by nocturnal BP detection, recording bias, and arbitrary selfmodification of treatment by anxious patients. Given their advantages and disadvantages, HBPM and ABPM should be considered to be complementary rather than competitive in managing hypertension. Our pro posed clinical procedure for using outofoffice BP monitoring is presented in Figure 2 .
To better incorporate outofoffice BP monitoring into clinical practice, initiatives should also be taken regarding the following. First, physicians need to be aware of the indications and limitations of outof office BP measurement. Second, patients should receive clearer instructions, training, and education regarding BP monitoring. Third, ideally, govern ments and public health researchers will engage in efforts to address costeffective methods of outof office BP monitoring. Fourth, combining remote data transmission with cliniccentered monitor ing is helpful in avoiding the drawbacks of HBPM, such as recording bias and arbitrary 
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